|
|
||||||||
Ann Thorac Surg 2006;81:2338
© 2006 The Society of Thoracic Surgeons
Department of Infectious and Parasitic Diseases, School Of Medicine, University of São Paulo, Av. Dr. Enéas de Carvalho Aguiar, 255 Cerqueira César, São Paulo, SP 05403-000 Brazil
(Email: ffbt@pop.com.br).
| The first 20% of the full text of this article appears below. |
To the Editor:
We read with interest the article by Georghiou and colleagues [1] and agree with their approach to pericardial effusions. In areas where the incidence of tuberculosis is high, pericardial effusion is always a challenge. Often patients are treated empirically with anti-tuberculous drugs, which may cause toxicity and adverse events. This is
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |